Published in Int J Cancer on January 03, 1995
Systematic review of factors influencing patient and practitioner delay in diagnosis of upper gastrointestinal cancer. Br J Cancer (2006) 1.96
Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci U S A (1996) 1.53
Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev (2013) 1.53
Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries. Am J Public Health (2006) 1.39
Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol (1999) 1.23
DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/E7 primer mediated multiplex PCR. J Clin Pathol (1998) 1.04
Social class and cancer survival in Turin, Italy. J Epidemiol Community Health (1997) 1.03
Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006. BMC Public Health (2012) 1.02
The costs of reducing loss to follow-up in South African cervical cancer screening. Cost Eff Resour Alloc (2005) 0.99
Epidemiology of HPV in HIV-positive and HIV-negative fertile women in Cameroon, West Africa. Infect Dis Obstet Gynecol (2010) 0.89
Optimizing cancer care through mobile health. Support Care Cancer (2015) 0.89
Interphase cytogenetic analysis of cervical intraepithelial neoplasia. Am J Pathol (1998) 0.88
Comparative study of effectiveness of Pap smear versus visual inspection with acetic acid and visual inspection with Lugol's iodine for mass screening of premalignant and malignant lesion of cervix. Indian J Med Paediatr Oncol (2012) 0.87
HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3. Br J Cancer (2003) 0.86
Do women >or=50 years of age need as much screening as women <50 years after they have had negative screening results? Br J Cancer (2008) 0.85
Changing trends in the incidence (1999-2011) and mortality (1983-2013) of cervical cancer in the Republic of Korea. Epidemiol Health (2015) 0.84
Are human papillomavirus infections not necessary or sufficient causal factors for invasive cancer of the cervix? Int J Cancer (1995) 0.83
Cervical cancer in Kerala: a hospital registry-based study on survival and prognostic factors. Br J Cancer (1995) 0.82
Cervical cancer screening: knowledge, health perception and attendance rate among Hong Kong Chinese women. Int J Womens Health (2010) 0.82
Human papilloma virus detection by in situ hybridisation signal amplification based on biotinylated tyramine deposition. Clin Mol Pathol (1996) 0.82
Microarray analysis of DNA damage repair gene expression profiles in cervical cancer cells radioresistant to 252Cf neutron and X-rays. BMC Cancer (2010) 0.81
Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients. Mol Pathol (2003) 0.81
'I do not need to... I do not want to... I do not give it priority...'--why women choose not to attend cervical cancer screening. Health Expect (2008) 0.81
Expression of serum amyloid A in uterine cervical cancer. Diagn Pathol (2014) 0.81
Additional human papillomavirus types detected by the hybrid capture tube test among samples from women with cytological and colposcopical atypia. J Clin Microbiol (2000) 0.79
Epidemiological aspects of cancer screening in Germany. J Cancer Res Clin Oncol (2003) 0.79
Seminal plasma enhances cervical adenocarcinoma cell proliferation and tumour growth in vivo. PLoS One (2012) 0.78
Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe. Infect Agent Cancer (2014) 0.78
Retracted Production of interleukin‑4 in CD133+ cervical cancer stem cells promotes resistance to apoptosis and initiates tumor growth. Mol Med Rep (2016) 0.77
Clonality analysis of synchronous lesions of cervical carcinoma based on X chromosome inactivation polymorphism, human papillomavirus type 16 genome mutations, and loss of heterozygosity. J Exp Med (2002) 0.76
Diagnostic, therapeutic and evolutionary characteristics of cervical cancer in Department of Radiotherapy, Mohamed V Military Hospital - Rabat in Morocco. Gynecol Oncol Res Pract (2015) 0.75
Predictors of default from follow-up care in a cervical cancer screening program using direct visual inspection in south-western Nigeria. BMC Health Serv Res (2014) 0.75
Screening, case finding or primary cancer prevention in the developing world? Eur J Epidemiol (2013) 0.75
Reporting results of cancer treatment. Cancer (1981) 28.83
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer (2010) 10.61
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer (1999) 6.11
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst (1995) 5.93
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med (1998) 5.66
Rapid diagnosis of bacteremia with quantitative differential-membrane filtration culture. JAMA (1966) 5.66
Cancer registration: principles and methods. Statistical methods for registries. IARC Sci Publ (1991) 5.44
Birthweight as a risk factor for breast cancer. Lancet (1996) 5.05
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr (1995) 4.50
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med (1996) 4.25
Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry (2001) 4.15
Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Canadian National Breast Screening Study: assessment of technical quality by external review. AJR Am J Roentgenol (1990) 3.98
Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96
Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst (1999) 3.88
A cohort study of cervical cancer screening in British Columbia. Clin Invest Med (1982) 3.80
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79
Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer (2000) 3.79
Coffee and cancer of the pancreas. N Engl J Med (1981) 3.79
The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77
Diet and overall survival in elderly people. BMJ (1995) 3.73
Stressful life events and Graves' disease. Lancet (1991) 3.63
Parity, age at first childbirth, and risk of ovarian cancer. Lancet (1994) 3.48
Should the mission of epidemiology include the eradication of poverty? Lancet (1998) 3.42
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37
Deviation from prescribed drug treatment after discharge from hospital. Br Med J (1976) 3.35
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol (1993) 3.33
Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ (1984) 3.32
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst (2001) 3.28
Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst (1993) 3.25
Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer (2011) 3.23
Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer (2002) 3.17
Lung cancer and passive smoking. Int J Cancer (1981) 3.14
Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer (1993) 3.13
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine (1998) 3.10
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Effect of breast self-examination techniques on the risk of death from breast cancer. CMAJ (1997) 3.05
Lactation and cancer of the breast. A summary of an international study. Bull World Health Organ (1970) 3.04
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol Cell (2000) 3.01
Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ (1992) 2.99
A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) (1985) 2.98
Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada, and France: 1970-1989. Am J Epidemiol (1994) 2.94
Lactation and reproductive histories of breast cancer patients in greater Athens, 1965-67. Int J Cancer (1969) 2.93
Coffee, pancreatic cancer and the question of causation. J Epidemiol Community Health (2000) 2.92
Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88
Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res (2000) 2.88
The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol (1985) 2.83
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology (1996) 2.83
Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer (1990) 2.82
History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst (2000) 2.82
Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81
Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med (1999) 2.79
Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.69
Evidence for interaction between air pollution and high temperature in the causation of excess mortality. Arch Environ Health (1993) 2.67
Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer (1997) 2.65
Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.65
Risk factor patterns for cryptorchidism and hypospadias. Epidemiology (1999) 2.64
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61